Clinical Trials Logo

Clinical Trial Summary

This study will collect information on (tricks) patients with focal dystonia use to relieve their symptoms. Dystonia is a movement disorder caused by sustained muscle contractions often causing twisting and abnormal posturing. Dystonia may be generalized, affecting at least one leg and the trunk of the body, segmental, affecting adjacent body parts, or focal, affecting a single body part, such as the hand or eyelid. It may be task-specific, such as writer's, musician's or sportsman's cramps. Some patients with focal dystonia use (tricks), such as touching the face or hand, to stop or alleviate the abnormal movement. This study will survey the types of tricks people with focal dystonia use in order to learn more about the disorder.

Patients 18 years of age and older with focal dystonia may be eligible for this study. Candidates will be screened for eligibility with a medical history, clinical evaluation, and review of their medical records.

In one 30- to 45-minute clinic visit, participants will be interviewed about their dystonia symptoms and the tricks they use to relieve the symptoms. They may be asked to show the investigators how the tricks work


Clinical Trial Description

The purpose of this study is to collect and organize information concerning a phenomenon known as 'sensory tricks' or Geste antagoniste in focal dystonia. Sensory tricks, which we will refer to as 'tricks' since some involve motor as well as sensory input, are various stimuli used by dystonic patients to transiently diminish their spasms (Jankovic and Fahn 1993). The phenomenon of tricks is evidence for the abnormality of sensorimotor integration in focal dystonia, yet it is little studied or understood. A survey of the history and characteristics of tricks will lead to a better understanding of this puzzling phenomenon, and a step toward the understanding of the mechanism of focal dystonia. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT00054652
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase N/A
Start date February 2003
Completion date February 2005

See also
  Status Clinical Trial Phase
Completed NCT04692285 - Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia Phase 1
Completed NCT00505323 - Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness Phase 1
Terminated NCT03206112 - Loss of Depotentiation in Focal Dystonia
Completed NCT00025701 - EEG and EMG Studies of Hand Dystonia N/A
Completed NCT02334683 - Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia N/A
Completed NCT03797638 - Characterization of Manual Dexterity by Finger Force Manipuladum (FFM) in Patients With Writer's Cramp and in Control Subjects N/A
Terminated NCT01750346 - Acetyl Hexapeptide-8 for Blepharospasm Phase 2
Completed NCT01738581 - rTMS and Retraining in Focal Hand Dystonia Phase 1/Phase 2
Terminated NCT02106936 - Depotentiation in People With Focal Hand Dystonia N/A
Completed NCT00310414 - fMRI Studies of Task Specificity in Focal Hand Dystonia N/A
Completed NCT00309010 - Neurophysiology of Task-Specificity of Focal Hand Dystonia N/A
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Completed NCT00306865 - Brain Changes in Patients With Focal Hand Dystonia N/A
Completed NCT00411255 - Brain Stimulation to Treat Blepharospasm or Meige Syndrome Phase 2
Terminated NCT00487383 - Brain Changes in Blepharospasm
Recruiting NCT05095740 - Effects of Neuromodulation in Laryngeal Dystonia N/A
Completed NCT00713414 - Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
Completed NCT00942851 - A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm Phase 1/Phase 2
Completed NCT00118586 - Neuropathology of Spasmodic Dysphonia
Completed NCT02326818 - Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity Phase 3